Kadsurenone and other related lignans as antagonists of platelet-activating factor receptor
Shen, T.Y.; Hussaini, I.M.
Methods in Enzymology 187: 446-454
1990
ISSN/ISBN: 0076-6879 PMID: 2172742 Document Number: 348064
Document emailed within 1 workday
Related Documents
Montrucchio, G.; Alloatti, G.; Mariano, F.; Tetta, C.; Emanuelli, G.; Camussi, G. 1986: Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist International Journal of Tissue Reactions 8(6): 497-504Hwang, S.B.; Li, C.L.; Lam, M.H.; Shen, T.Y. 1985: Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist Laboratory Investigation; a Journal of Technical Methods and Pathology 52(6): 617-630
Floch, A.; Tahraoui, L.; Sedivy, P.; Cavero, I. 1991: The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes Journal of Pharmacology and Experimental Therapeutics 258(2): 567-575
Hwang, S.B.; Lam, M.H.; Hsu, A.H. 1989: Characterization of platelet-activating factor (PAF) receptor by specific binding of [3H]L-659,989, a PAF receptor antagonist, to rabbit platelet membranes: possible multiple conformational states of a single type of PAF receptors Molecular Pharmacology 35(1): 48-58
Muacevic, G.; Heuer, H.O. 1992: Platelet-activating factor antagonists in experimental shock Arzneimittel-Forschung 42(8): 1001-1004
Issekutz, A.C.; Szpejda, M. 1986: Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988 Laboratory Investigation; a Journal of Technical Methods and Pathology 54(3): 275-281
Lakin, K.M.; Kulikov, V.I.; Manevich, E.M.; Muliar, A.G.; Shvets, V.I. 1988: Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation Farmakologiia i Toksikologiia 51(4): 113-123
Nechifor, M.; Neughebauer, I.B.; Costuleanu, M.; Alomnicăi, M.; Teslaru, E.; Filip, C.; Cocu, F. 1993: The influence of an PGF2x analogue and of some peptidoleukotrienes and platelet activating factor antagonists in experimentally induced gastric ulcer in rats Romanian Journal of Physiology 30(3-4): 155-159
Handley, D.A.; Van Valen, R.G.; Melden, M.K.; Houlihan, W.J.; Saunders, R.N. 1988: Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412 Journal of Pharmacology and Experimental Therapeutics 247(2): 617-623
Fernández-Gallardo, S.; Ortega, M.P.; Priego, J.G.; de Casa-Juana, M.F.; Sunkel, C.; Sánchez Crespo, M. 1990: Pharmacological actions of PCA 4248, a new platelet-activating factor receptor antagonist: in vivo studies Journal of Pharmacology and Experimental Therapeutics 255(1): 34-39
Asai, Y. 2005: Formation of spherical micelles composed of the novel platelet activating factor receptor antagonist, E5880 Die Pharmazie 60(3): 201-204
Ouellet, S.; Müller, E.; Rola-Pleszczynski, M. 1994: IFN-gamma up-regulates platelet-activating factor receptor gene expression in human monocytes Journal of Immunology 152(10): 5092-5099
Chen, J.; Giri, S.N. 1997: Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages Journal of Pharmacology and Experimental Therapeutics 281(3): 1047-1058
Tsai, M.H.; Chiou, S.H.; Chow, K.C. 2001: Effect of platelet activating factor and butyrate on the expression of interleukin-2 receptor alpha in nasopharyngeal carcinoma cells International Journal of Oncology 19(5): 1049-1055
Oztürk, H.; Oztürk, H.; Dokucu, A.I.; Otcu, S. 2006: Effects of lexipafant (BB-882), a platelet activating factor receptor antagonist, on liver damage due to bile duct ligation in rats Acta Gastro-Enterologica Belgica 69(2): 197-202
Perico, N.; Delaini, F.; Tagliaferri, M.; Abbate, M.; Cucchi, M.; Bertani, T.; Remuzzi, G. 1988: Effect of platelet-activating factor and its specific receptor antagonist on glomerular permeability to proteins in isolated perfused rat kidney Laboratory Investigation; a Journal of Technical Methods and Pathology 58(2): 163-171
Seguchi, M.; Nakajima, S. 1995: Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4 Annals of Allergy Asthma and Immunology: Official Publication of the American College of Allergy Asthma and Immunology 74(3): 255-257
Nolte, D. 1989: Platelet activating factor produces platelet activating factor, comes to nothing Medizinische Klinik 84(6): 319-320
Macpherson, J.L.; Kemp, A.; Rogers, M.; Mallet, A.I.; Toia, R.F.; Spur, B.; Earl, J.W.; Chesterman, C.N.; Krilis, S.A. 1989: Occurrence of platelet-activating factor (PAF) and an endogenous inhibitor of platelet aggregation in diffuse cutaneous mastocytosis Clinical and Experimental Immunology 77(3): 391-396
Farr, R.S.; Wardlow, M.L.; Cox, C.P.; Meng, K.E.; Greene, D.E. 1983: Human serum acid-labile factor is an acylhydrolase that inactivates platelet-activating factor Federation Proceedings 42(14): 3120-3122